other material
confidence high
sentiment neutral
materiality 0.55
Alzamend Neuro issues 361,743 shares on Series B Preferred conversion
Alzamend Neuro, Inc.
- Between Oct 1-8, 2025, 361,743 shares issued upon conversion of ~839.2 Series B Convertible Preferred shares.
- Shares issued under Section 4(a)(2) exemption from registration.
- As of Oct 8, 2025, total common shares outstanding: 3,801,604.
- Conversion increases outstanding share count by roughly 10.5% from prior level.